| Trial registration number
|
NCT05689229 |
Full text link
Last imported at : Jan. 20, 2023, 8 a.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT05689229
|
First author
Last imported at : Jan. 20, 2023, 8 a.m.
Source : ClinicalTrials.gov
|
Not reported
|
Contact
Last imported at : Jan. 20, 2023, 8 a.m.
Source : ClinicalTrials.gov
|
Not reported
|
Registration date
Last imported at : Jan. 20, 2023, 8 a.m.
Source : ClinicalTrials.gov
|
2023-01-19
|
Recruitment status
Last imported at : Jan. 20, 2023, 8 a.m.
Source : ClinicalTrials.gov
|
Completed
|
Study design
Last imported at : Jan. 20, 2023, 8 a.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : Jan. 20, 2023, 8 a.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : Jan. 20, 2023, 8 a.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : Jan. 20, 2023, 8 a.m.
Source : ClinicalTrials.gov
|
Open label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : Jan. 20, 2023, 8 a.m.
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : Jan. 20, 2023, 8 a.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
covid-19 patients with secondary gram-negative bacterial infections
|
Exclusion criteria
Last imported at : Jan. 20, 2023, 8 a.m.
Source : ClinicalTrials.gov
|
patients with resistant bacterial strains to polymyxins
patients less than 18 years
|
Number of arms
Last imported at : Jan. 20, 2023, 8 a.m.
Source : ClinicalTrials.gov
|
3
|
Funding
Last imported at : Jan. 20, 2023, 8 a.m.
Source : ClinicalTrials.gov
|
Beni-Suef University
|
Inclusion age min
Last imported at : Jan. 20, 2023, 8 a.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : Jan. 20, 2023, 8 a.m.
Source : ClinicalTrials.gov
|
70
|
Countries
Last imported at : Jan. 20, 2023, 8 a.m.
Source : ClinicalTrials.gov
|
Egypt
|
Type of patients
Last imported at : Jan. 20, 2023, 8 a.m.
Source : ClinicalTrials.gov
|
No restriction on type of patients
|
Severity scale
Last imported at : Jan. 20, 2023, 8 a.m.
Source : ClinicalTrials.gov
|
0: No restriction on type of patients
|
Total sample size
Last imported at : Jan. 20, 2023, 8 a.m.
Source : ClinicalTrials.gov
|
128
|
primary outcome
Last imported at : Jan. 20, 2023, 8 a.m.
Source : ClinicalTrials.gov
|
Microbial eradication;Mortality
|
Notes
Last imported at : Jan. 20, 2023, 8 a.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Jan. 20, 2023, 8 a.m.
Source : ClinicalTrials.gov
|
Phase 3
|
Arms
Last imported at : Jan. 20, 2023, 8 a.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "Aerosolized", "treatment_id": 2683, "treatment_name": "Colistin", "treatment_type": "Antibiotics", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "Intravenous", "treatment_id": 2683, "treatment_name": "Colistin", "treatment_type": "Antibiotics", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]
|